Results 31 to 40 of about 9,369 (213)

Quantitative and qualitative analysis of the antifungal activity of allicin alone and in combination with antifungal drugs. [PDF]

PLoS ONE, 2012
The antifungal activity of allicin and its synergistic effects with the antifungal agents flucytosine and amphotericin B (AmB) were investigated in Candida albicans (C. albicans). C.
Young-Sun Kim, Kyung Sook Kim, Ihn Han, Mi-Hyun Kim, Min Hyung Jung, Hun-Kuk Park   +5 more
doaj   +1 more source

Malabsorption of Flucytosine in a Pediatric Patient with Shwachman Syndrome [PDF]

, 1989
The malabsorption of drugs from the gastrointestinal tract in patients with pancreatic insufficiency is not well documented in the literature. We describe a case of flucytosine malabsorption in a pediatric patient with Shwachman syndrome, a rare disease
Karen J. Harper, William T. Sawyer
core   +1 more source

Short-Course Rather Than Low-Dose Amphotericin B May Exert Potential Influence on Mortality in Cryptococcal Meningitis Patients Treated With Amphotericin B Plus Flucytosine Alone or in Combination With Fluconazole

Frontiers in Microbiology, 2019
BackgroundThe influence of Amphotericin B (AmB) dose and the addition of fluconazole (Flu) on the AmB + 5-flucytosine (5FC) regimen for cryptococcal meningitis (CM) treatment remain debatable.MethodsA retrospective study was conducted to compare 44 CM ...
Lijun Xu, Lijun Xu, Ran Tao, Ran Tao, Jingjing Wu, Xiahong Dai, Caiqin Hu, Ying Huang, YaoKai Chen, Biao Zhu, Biao Zhu, Jianqin He, Jianqin He   +12 more
doaj   +1 more source

In Vitro Characterization of Twenty-One Antifungal Combinations against Echinocandin-Resistant and -Susceptible Candida glabrata

Journal of Fungi, 2021
This study was designed to analyze the interaction of 21 antifungal combinations consisting of seven major antifungal agents against 11 echinocandin- susceptible and six-resistant C. glabrata isolates. The combinations were divided into five major groups
Hazim O. Khalifa, Hidetaka Majima, Akira Watanabe, Katsuhiko Kamei   +3 more
doaj   +1 more source

Antifungal Susceptibility of Saccharomyces cerevisiae Isolated from Clinical Specimens

Pathogens
(1) Background: Despite being considered a non-pathogenic yeast, recently, a growing occurrence of Saccharomyces cerevisiae infections has been noted. There is little knowledge about the drug susceptibility of this species.
Aleksandra Górzyńska, Kamila Kondracka, Agnieszka Korzeniowska-Kowal, Urszula Nawrot   +3 more
doaj   +1 more source

Does DHN-Melanin Always Protect Fungi against Antifungal Drugs? The Fonsecaea/Micafungin Paradigm

Microbiology Research, 2022
Several human pathogenic fungi produce melanin. One of its properties during parasitism is the protection against antifungal drugs. This occurs with the agents of chromoblastomycosis, in which DHN-melanin reduces antifungal susceptibility to terbinafine ...
Rowena Alves Coelho, Maria Helena Galdino Figueiredo-Carvalho, Juliana Vitória dos Santos Silva, Dario Correa-Junior, Susana Frases, Rosely Maria Zancopé-Oliveira, Dayvison Francis Saraiva Freitas, Rodrigo Almeida-Paes   +7 more
doaj   +1 more source

Flucytosine for treatment of Candida albicans in H1N1-positive patient [PDF]

, 2010
A 17-year-old H1N1-positive patient was successfully extubated after 25 days of ventilatory support for treatment of viral pneumonia which was complicated by empyema thoracis due to Candida albicans.
Desh Deepak, Yadav, Amlendu, Pawar, Mridula, Tanvir Samra, Mridula Pawar, Amlendu Yadav, Samra, Tanvir, Banerjee, Neerja, Deepak, Desh, Neerja Banerjee   +9 more
core   +1 more source

Quantitative and qualitative analyses of the cell death process in Candida albicans treated by antifungal agents. [PDF]

PLoS ONE, 2011
The death process of Candida albicans was investigated after treatment with the antifungal agents flucytosine and amphotericin B by assessing morphological and biophysical properties associated with cell death. C.
Kyung Sook Kim, Young-Sun Kim, Ihn Han, Mi-Hyun Kim, Min Hyung Jung, Hun-Kuk Park   +5 more
doaj   +1 more source

Stability and bioavailability of a flucytosine suspension [PDF]

, 1994
The stability and bioavailability of a suspension of flucytosine was evaluated. There was found to be no change in the flucytosine content of the suspension over a three month period.
R H Pryce-Jones, J R Johnson, D C McPhail   +2 more
core   +1 more source

Flucytosine and cryptococcosis : which in vitro test is the best predictor of outcome? [PDF]

, 2003
The combination of flucytosine and amphotericin B is first choice treatment for active cryptococcosis. Because of innate or acquired resistance of Cryptococcus neoformans to flucytosine, in vitro testing is mandatory.
A.M. Tortorano, M.C. Esposto, M.A. Savoldelli, M. Cogliati   +3 more
core   +1 more source